Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
    • About us 
      • Board of Trustees 
        • Giovanni Caforio, M.D. 
        • Ann Aerts, M.D. 
        • Prof. Dr. Jo Ivey Boufford 
        • John Damonti 
        • John Kahan 
        • Prof. Peter Piot, M.D. 
        • Andreas von Planta, Ph.D. 
      • Our partners 
      Close up portrait of a smiling HCP

      About us

      Imagining healthier cities where everyone can thrive.

    • Our programs 
      • CARDIO4Cities 
      • AI4HealthyCities 
      Dad and daughter looking at a city skyline

      Our programs

      Turning data-driven insight into measurable health impact in cities.

    • Urban Population Health Toolkit 
      • Quality of care 
      • Ensure access 
      • Policy reform 
      • Leverage data and digital 
      • Intersectoral collaboration 
      • Ensure local ownership 
      Patients getting screened in a community health camp in Vietnam
      Urban Population Health Toolkit
    • Past programs 
      • Better Hearts Better Cities 
        • Community-based Hypertension Improvement Project (ComHIP) 
        • Communities for Healthy Hearts 
        • KaziBantu (Healthy Schools for Healthy Communities) 
      • Leprosy and malaria elimination 
        • The Leprosy Alert and Response Network System (LEARNS) 
        • Leprosy Post-Exposure Prophylaxis (LPEP) program 
        • Malaria Targeted Parasite Elimination Strategy 
      • Digital Health 
        • Ghana Telemedicine 
        • Telemedicine Toolkit 
        • Integrated e-Diagnostic Approach 
      Image of a female hypertension patient in Ghana in a healthcare location
      Past Programs
    • Media Center 
      • News Archive  
      • Media Library  
      • Stories 
      Family in front of their house participating in Leprosy Post-Exposure Prophylaxis (LPEP) Program in Nepal
      Media Center
    Image of three women presenting LEARNS App on their mobile phones
    Homepage
  1. Home
  2. Media Center
  3. Media Library
  4. An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia

An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia

Back to previous page
Cover image of the article about screening and chemoprophylaxis among contacts of leprosy patients
Description

The objective of the research article is to evaluate operational feasibility in a low-endemic leprosy setting to (a) maintain or revitalize contact tracing and (b) integrate SDR PEP into RACF.

An Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia (PDF 310.38 KB)

Related Items

  • Image of document cover
    Document
    lock
    Leprosy, Publication
    Leprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme
  • Cover image of the article regarding the leprosy diagnostic test development
    Document
    lock
    Leprosy, Publication
    Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective
  • Cover picture of the publication regarding leprosy control in routine settings
    Document
    lock
    Leprosy, Publication
    Minimal Essential Data to Document Contact Tracing and Single Dose Rifampicin (SDR) for Leprosy Control in Routine Settings: A Practical Guide
  • Cover of 2018 - CorNTD - Innovations in Leprosy Prophylaxis - Current Evidence and Upcoming Trials
    Document
    lock
    Leprosy, Publication
    Innovations in Leprosy Prophylaxis: Current Evidence and Upcoming Trials

Novartis Foundation

Navigate Novartis Foundation
  • About us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our partners
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2026 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience